Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank
暂无分享,去创建一个
K. Nathanson | M. Ritchie | S. Damrauer | S. Verma | A. Verma | R. Judy | R. Kember | D. Mowery | A. Doucette | P. Gabriel | K. Maxwell | A. Le | Louise Wang | H. Desai | R. Hausler
[1] C. Haiman,et al. Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer , 2021, Journal of the National Cancer Institute.
[2] Lara E Sucheston-Campbell,et al. Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. , 2021, Journal of the National Cancer Institute.
[3] James M. Hodge,et al. A Population-Based Study of Genes Previously Implicated in Breast Cancer. , 2021, The New England journal of medicine.
[4] K. D. Sørensen,et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction , 2021, Nature genetics.
[5] D. Easton,et al. CanRisk Tool—A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants , 2020, Cancer Epidemiology, Biomarkers & Prevention.
[6] Jaana M. Hartikainen,et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. , 2021, The New England journal of medicine.
[7] S. Cross,et al. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. , 2020, American journal of human genetics.
[8] C. Kooperberg,et al. Improving reporting standards for polygenic scores in risk prediction studies , 2020, Nature.
[9] M. Abdolell,et al. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening , 2020, European Radiology.
[10] J. Denny,et al. Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers , 2020, JNCI cancer spectrum.
[11] B. Meiser,et al. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field , 2020, Breast Cancer Research.
[12] Aung Ko Win,et al. A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental Factors , 2020, Cancer Epidemiology, Biomarkers & Prevention.
[13] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[14] K. D. Sørensen,et al. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations , 2019, Nature Communications.
[15] Dustin N. Hartzel,et al. A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes , 2019, Genetics in Medicine.
[16] M. Feldman,et al. Analysis of polygenic risk score usage and performance in diverse human populations , 2019, Nature Communications.
[17] Alicia R. Martin,et al. Clinical use of current polygenic risk scores may exacerbate health disparities , 2019, Nature Genetics.
[18] M. García-Closas,et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors , 2019, Genetics in Medicine.
[19] Kristen S Purrington,et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes , 2018, American Journal of Human Genetics.
[20] V. Viallon,et al. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts , 2018, Breast Cancer Research.
[21] Helen E. Parkinson,et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..
[22] O. Andreassen,et al. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts , 2018, British Medical Journal.
[23] P. Visscher,et al. Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores , 2015, bioRxiv.
[24] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[25] Stephen W Duffy,et al. Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I , 2014, Breast Cancer Research.
[26] K. Czene,et al. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement , 2012, Breast Cancer Research.
[27] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[28] Susanne B Haga,et al. Impact of limited population diversity of genome-wide association studies , 2010, Genetics in Medicine.
[29] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[30] Genome-wide association studies of cancer: current insights and future perspectives , 2022 .